nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—AOX1—Brimonidine—glaucoma	0.619	0.744	CbGbCtD
Pyrazinamide—CYP1A2—Betaxolol—glaucoma	0.0528	0.0634	CbGbCtD
Pyrazinamide—CYP3A4—Pilocarpine—glaucoma	0.0311	0.0373	CbGbCtD
Pyrazinamide—CYP1A2—Clonidine—glaucoma	0.0289	0.0348	CbGbCtD
Pyrazinamide—CYP3A4—Brinzolamide—glaucoma	0.0244	0.0293	CbGbCtD
Pyrazinamide—CYP3A4—Dorzolamide—glaucoma	0.0235	0.0283	CbGbCtD
Pyrazinamide—CYP3A4—Methazolamide—glaucoma	0.021	0.0252	CbGbCtD
Pyrazinamide—CYP3A4—Acetazolamide—glaucoma	0.0168	0.0201	CbGbCtD
Pyrazinamide—CYP3A4—Clonidine—glaucoma	0.0152	0.0182	CbGbCtD
Pyrazinamide—Digestion impaired—Diclofenamide—glaucoma	0.00431	0.0266	CcSEcCtD
Pyrazinamide—Digestion impaired—Methazolamide—glaucoma	0.00397	0.0245	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Diclofenamide—glaucoma	0.00311	0.0192	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Diclofenamide—glaucoma	0.00293	0.0181	CcSEcCtD
Pyrazinamide—Digestion impaired—Acetazolamide—glaucoma	0.00275	0.0169	CcSEcCtD
Pyrazinamide—Peptic ulcer—Travoprost—glaucoma	0.00251	0.0155	CcSEcCtD
Pyrazinamide—Digestion impaired—Brinzolamide—glaucoma	0.00248	0.0153	CcSEcCtD
Pyrazinamide—Hepatomegaly—Dorzolamide—glaucoma	0.00238	0.0147	CcSEcCtD
Pyrazinamide—Photosensitivity—Methazolamide—glaucoma	0.00219	0.0135	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Methazolamide—glaucoma	0.00152	0.00937	CcSEcCtD
Pyrazinamide—Photosensitivity—Acetazolamide—glaucoma	0.00152	0.00937	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Brinzolamide—glaucoma	0.0015	0.00928	CcSEcCtD
Pyrazinamide—Vomiting—Physostigmine—glaucoma	0.0015	0.00926	CcSEcCtD
Pyrazinamide—Hypersensitivity—Dipivefrin—glaucoma	0.00148	0.00913	CcSEcCtD
Pyrazinamide—Nausea—Physostigmine—glaucoma	0.0014	0.00865	CcSEcCtD
Pyrazinamide—Hepatomegaly—Timolol—glaucoma	0.00128	0.00787	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Betaxolol—glaucoma	0.00119	0.00735	CcSEcCtD
Pyrazinamide—Gout—Betaxolol—glaucoma	0.00118	0.00731	CcSEcCtD
Pyrazinamide—Myalgia—Metipranolol—glaucoma	0.00118	0.00726	CcSEcCtD
Pyrazinamide—Discomfort—Metipranolol—glaucoma	0.00116	0.00718	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Clonidine—glaucoma	0.00115	0.00712	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Betaxolol—glaucoma	0.00113	0.00695	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Methazolamide—glaucoma	0.00108	0.00664	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Acetazolamide—glaucoma	0.00105	0.00649	CcSEcCtD
Pyrazinamide—Malaise—Methazolamide—glaucoma	0.00105	0.00645	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Metipranolol—glaucoma	0.00103	0.00634	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Diclofenamide—glaucoma	0.00101	0.00621	CcSEcCtD
Pyrazinamide—Dysuria—Dorzolamide—glaucoma	0.000988	0.00609	CcSEcCtD
Pyrazinamide—Dysuria—Travoprost—glaucoma	0.000983	0.00607	CcSEcCtD
Pyrazinamide—Anorexia—Diclofenamide—glaucoma	0.00098	0.00604	CcSEcCtD
Pyrazinamide—Discomfort—Methazolamide—glaucoma	0.000976	0.00602	CcSEcCtD
Pyrazinamide—Arthralgia—Latanoprost—glaucoma	0.000956	0.0059	CcSEcCtD
Pyrazinamide—Discomfort—Latanoprost—glaucoma	0.000944	0.00583	CcSEcCtD
Pyrazinamide—Dysuria—Pilocarpine—glaucoma	0.000933	0.00576	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Pilocarpine—glaucoma	0.000911	0.00562	CcSEcCtD
Pyrazinamide—Dyspepsia—Diclofenamide—glaucoma	0.000905	0.00558	CcSEcCtD
Pyrazinamide—Anorexia—Methazolamide—glaucoma	0.000902	0.00557	CcSEcCtD
Pyrazinamide—Decreased appetite—Diclofenamide—glaucoma	0.000894	0.00551	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Diclofenamide—glaucoma	0.000888	0.00547	CcSEcCtD
Pyrazinamide—Dyspepsia—Carbachol—glaucoma	0.000883	0.00545	CcSEcCtD
Pyrazinamide—Feeling abnormal—Diclofenamide—glaucoma	0.000847	0.00523	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Latanoprost—glaucoma	0.000835	0.00515	CcSEcCtD
Pyrazinamide—Dyspepsia—Methazolamide—glaucoma	0.000833	0.00514	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Apraclonidine—glaucoma	0.000833	0.00514	CcSEcCtD
Pyrazinamide—Hypersensitivity—Metipranolol—glaucoma	0.000832	0.00513	CcSEcCtD
Pyrazinamide—Decreased appetite—Methazolamide—glaucoma	0.000823	0.00508	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Methazolamide—glaucoma	0.000817	0.00504	CcSEcCtD
Pyrazinamide—Feeling abnormal—Levobunolol—glaucoma	0.000814	0.00502	CcSEcCtD
Pyrazinamide—Body temperature increased—Diclofenamide—glaucoma	0.000813	0.00501	CcSEcCtD
Pyrazinamide—Malaise—Apraclonidine—glaucoma	0.000809	0.00499	CcSEcCtD
Pyrazinamide—Hepatitis—Pilocarpine—glaucoma	0.000799	0.00493	CcSEcCtD
Pyrazinamide—Body temperature increased—Carbachol—glaucoma	0.000793	0.00489	CcSEcCtD
Pyrazinamide—Urticaria—Levobunolol—glaucoma	0.000785	0.00484	CcSEcCtD
Pyrazinamide—Feeling abnormal—Methazolamide—glaucoma	0.00078	0.00481	CcSEcCtD
Pyrazinamide—Hypersensitivity—Carteolol—glaucoma	0.00077	0.00475	CcSEcCtD
Pyrazinamide—Myalgia—Apraclonidine—glaucoma	0.000764	0.00471	CcSEcCtD
Pyrazinamide—Discomfort—Apraclonidine—glaucoma	0.000755	0.00466	CcSEcCtD
Pyrazinamide—Urticaria—Methazolamide—glaucoma	0.000752	0.00464	CcSEcCtD
Pyrazinamide—Body temperature increased—Methazolamide—glaucoma	0.000748	0.00462	CcSEcCtD
Pyrazinamide—Dysuria—Clonidine—glaucoma	0.000745	0.0046	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Acetazolamide—glaucoma	0.000745	0.00459	CcSEcCtD
Pyrazinamide—Hypersensitivity—Levobunolol—glaucoma	0.000728	0.00449	CcSEcCtD
Pyrazinamide—Pruritus—Diclofenamide—glaucoma	0.000727	0.00449	CcSEcCtD
Pyrazinamide—Malaise—Acetazolamide—glaucoma	0.000724	0.00447	CcSEcCtD
Pyrazinamide—Rash—Metipranolol—glaucoma	0.000712	0.00439	CcSEcCtD
Pyrazinamide—Dermatitis—Metipranolol—glaucoma	0.000711	0.00439	CcSEcCtD
Pyrazinamide—Pruritus—Levobunolol—glaucoma	0.000699	0.00431	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Travoprost—glaucoma	0.00068	0.00419	CcSEcCtD
Pyrazinamide—Discomfort—Acetazolamide—glaucoma	0.000675	0.00417	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Brinzolamide—glaucoma	0.000671	0.00414	CcSEcCtD
Pyrazinamide—Nausea—Metipranolol—glaucoma	0.00067	0.00414	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.000667	0.00412	CcSEcCtD
Pyrazinamide—Malaise—Travoprost—glaucoma	0.000661	0.00408	CcSEcCtD
Pyrazinamide—Myalgia—Brimonidine—glaucoma	0.000656	0.00405	CcSEcCtD
Pyrazinamide—Arthralgia—Brimonidine—glaucoma	0.000656	0.00405	CcSEcCtD
Pyrazinamide—Vomiting—Diclofenamide—glaucoma	0.000654	0.00403	CcSEcCtD
Pyrazinamide—Malaise—Brinzolamide—glaucoma	0.000652	0.00402	CcSEcCtD
Pyrazinamide—Dysuria—Betaxolol—glaucoma	0.000649	0.004	CcSEcCtD
Pyrazinamide—Pruritus—Latanoprost—glaucoma	0.000648	0.004	CcSEcCtD
Pyrazinamide—Rash—Diclofenamide—glaucoma	0.000648	0.004	CcSEcCtD
Pyrazinamide—Discomfort—Brimonidine—glaucoma	0.000648	0.004	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Acetazolamide—glaucoma	0.000642	0.00396	CcSEcCtD
Pyrazinamide—Vomiting—Carbachol—glaucoma	0.000638	0.00394	CcSEcCtD
Pyrazinamide—Hepatitis—Clonidine—glaucoma	0.000638	0.00393	CcSEcCtD
Pyrazinamide—Rash—Carbachol—glaucoma	0.000633	0.0039	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000632	0.0039	CcSEcCtD
Pyrazinamide—Dermatitis—Carbachol—glaucoma	0.000632	0.0039	CcSEcCtD
Pyrazinamide—Arthralgia—Dorzolamide—glaucoma	0.000626	0.00386	CcSEcCtD
Pyrazinamide—Dyspepsia—Bimatoprost—glaucoma	0.000625	0.00386	CcSEcCtD
Pyrazinamide—Arthralgia—Travoprost—glaucoma	0.000624	0.00385	CcSEcCtD
Pyrazinamide—Myalgia—Travoprost—glaucoma	0.000624	0.00385	CcSEcCtD
Pyrazinamide—Nausea—Carteolol—glaucoma	0.000621	0.00383	CcSEcCtD
Pyrazinamide—Discomfort—Dorzolamide—glaucoma	0.000619	0.00382	CcSEcCtD
Pyrazinamide—Discomfort—Travoprost—glaucoma	0.000616	0.0038	CcSEcCtD
Pyrazinamide—Arthralgia—Brinzolamide—glaucoma	0.000616	0.0038	CcSEcCtD
Pyrazinamide—Myalgia—Brinzolamide—glaucoma	0.000616	0.0038	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000613	0.00378	CcSEcCtD
Pyrazinamide—Nausea—Diclofenamide—glaucoma	0.000611	0.00377	CcSEcCtD
Pyrazinamide—Discomfort—Brinzolamide—glaucoma	0.000609	0.00375	CcSEcCtD
Pyrazinamide—Feeling abnormal—Apraclonidine—glaucoma	0.000604	0.00372	CcSEcCtD
Pyrazinamide—Vomiting—Methazolamide—glaucoma	0.000602	0.00371	CcSEcCtD
Pyrazinamide—Rash—Methazolamide—glaucoma	0.000597	0.00368	CcSEcCtD
Pyrazinamide—Dermatitis—Methazolamide—glaucoma	0.000596	0.00368	CcSEcCtD
Pyrazinamide—Nausea—Carbachol—glaucoma	0.000596	0.00368	CcSEcCtD
Pyrazinamide—Arthralgia—Pilocarpine—glaucoma	0.000592	0.00365	CcSEcCtD
Pyrazinamide—Myalgia—Pilocarpine—glaucoma	0.000592	0.00365	CcSEcCtD
Pyrazinamide—Nausea—Levobunolol—glaucoma	0.000587	0.00362	CcSEcCtD
Pyrazinamide—Discomfort—Pilocarpine—glaucoma	0.000585	0.00361	CcSEcCtD
Pyrazinamide—Rash—Latanoprost—glaucoma	0.000578	0.00356	CcSEcCtD
Pyrazinamide—Dermatitis—Latanoprost—glaucoma	0.000577	0.00356	CcSEcCtD
Pyrazinamide—Dyspepsia—Acetazolamide—glaucoma	0.000577	0.00356	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000573	0.00353	CcSEcCtD
Pyrazinamide—Anorexia—Dorzolamide—glaucoma	0.000572	0.00353	CcSEcCtD
Pyrazinamide—Decreased appetite—Acetazolamide—glaucoma	0.00057	0.00351	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000566	0.00349	CcSEcCtD
Pyrazinamide—Nausea—Methazolamide—glaucoma	0.000562	0.00347	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Pilocarpine—glaucoma	0.000556	0.00343	CcSEcCtD
Pyrazinamide—Dyspepsia—Brimonidine—glaucoma	0.000554	0.00341	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000547	0.00338	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Travoprost—glaucoma	0.000545	0.00336	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Brimonidine—glaucoma	0.000543	0.00335	CcSEcCtD
Pyrazinamide—Anorexia—Pilocarpine—glaucoma	0.000541	0.00334	CcSEcCtD
Pyrazinamide—Feeling abnormal—Acetazolamide—glaucoma	0.00054	0.00333	CcSEcCtD
Pyrazinamide—Hypersensitivity—Apraclonidine—glaucoma	0.00054	0.00333	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000538	0.00332	CcSEcCtD
Pyrazinamide—Dysuria—Timolol—glaucoma	0.00053	0.00327	CcSEcCtD
Pyrazinamide—Dyspepsia—Dorzolamide—glaucoma	0.000529	0.00326	CcSEcCtD
Pyrazinamide—Dyspepsia—Travoprost—glaucoma	0.000526	0.00325	CcSEcCtD
Pyrazinamide—Decreased appetite—Dorzolamide—glaucoma	0.000522	0.00322	CcSEcCtD
Pyrazinamide—Urticaria—Acetazolamide—glaucoma	0.000521	0.00321	CcSEcCtD
Pyrazinamide—Dyspepsia—Brinzolamide—glaucoma	0.00052	0.00321	CcSEcCtD
Pyrazinamide—Pruritus—Apraclonidine—glaucoma	0.000518	0.0032	CcSEcCtD
Pyrazinamide—Body temperature increased—Acetazolamide—glaucoma	0.000518	0.0032	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000517	0.00319	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Travoprost—glaucoma	0.000516	0.00318	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Clonidine—glaucoma	0.000515	0.00318	CcSEcCtD
Pyrazinamide—Decreased appetite—Brinzolamide—glaucoma	0.000513	0.00317	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00051	0.00314	CcSEcCtD
Pyrazinamide—Pruritus—Bimatoprost—glaucoma	0.000502	0.0031	CcSEcCtD
Pyrazinamide—Malaise—Clonidine—glaucoma	0.000501	0.00309	CcSEcCtD
Pyrazinamide—Dyspepsia—Pilocarpine—glaucoma	0.0005	0.00308	CcSEcCtD
Pyrazinamide—Feeling abnormal—Dorzolamide—glaucoma	0.000495	0.00305	CcSEcCtD
Pyrazinamide—Decreased appetite—Pilocarpine—glaucoma	0.000493	0.00304	CcSEcCtD
Pyrazinamide—Feeling abnormal—Travoprost—glaucoma	0.000493	0.00304	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00049	0.00302	CcSEcCtD
Pyrazinamide—Feeling abnormal—Brinzolamide—glaucoma	0.000487	0.003	CcSEcCtD
Pyrazinamide—Urticaria—Dorzolamide—glaucoma	0.000477	0.00294	CcSEcCtD
Pyrazinamide—Body temperature increased—Dorzolamide—glaucoma	0.000475	0.00293	CcSEcCtD
Pyrazinamide—Arthralgia—Clonidine—glaucoma	0.000473	0.00292	CcSEcCtD
Pyrazinamide—Urticaria—Brinzolamide—glaucoma	0.000469	0.00289	CcSEcCtD
Pyrazinamide—Feeling abnormal—Pilocarpine—glaucoma	0.000468	0.00288	CcSEcCtD
Pyrazinamide—Discomfort—Clonidine—glaucoma	0.000467	0.00288	CcSEcCtD
Pyrazinamide—Vomiting—Apraclonidine—glaucoma	0.000466	0.00287	CcSEcCtD
Pyrazinamide—Hypersensitivity—Brimonidine—glaucoma	0.000463	0.00286	CcSEcCtD
Pyrazinamide—Dermatitis—Apraclonidine—glaucoma	0.000461	0.00285	CcSEcCtD
Pyrazinamide—Body temperature increased—Pilocarpine—glaucoma	0.000449	0.00277	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Betaxolol—glaucoma	0.000449	0.00277	CcSEcCtD
Pyrazinamide—Rash—Bimatoprost—glaucoma	0.000448	0.00276	CcSEcCtD
Pyrazinamide—Dermatitis—Bimatoprost—glaucoma	0.000447	0.00276	CcSEcCtD
Pyrazinamide—Pruritus—Brimonidine—glaucoma	0.000445	0.00274	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Clonidine—glaucoma	0.000444	0.00274	CcSEcCtD
Pyrazinamide—Hypersensitivity—Dorzolamide—glaucoma	0.000442	0.00273	CcSEcCtD
Pyrazinamide—Hypersensitivity—Travoprost—glaucoma	0.000441	0.00272	CcSEcCtD
Pyrazinamide—Malaise—Betaxolol—glaucoma	0.000436	0.00269	CcSEcCtD
Pyrazinamide—Nausea—Apraclonidine—glaucoma	0.000435	0.00268	CcSEcCtD
Pyrazinamide—Hypersensitivity—Brinzolamide—glaucoma	0.000435	0.00268	CcSEcCtD
Pyrazinamide—Anorexia—Clonidine—glaucoma	0.000432	0.00266	CcSEcCtD
Pyrazinamide—Pruritus—Dorzolamide—glaucoma	0.000425	0.00262	CcSEcCtD
Pyrazinamide—Pruritus—Travoprost—glaucoma	0.000423	0.00261	CcSEcCtD
Pyrazinamide—Nausea—Bimatoprost—glaucoma	0.000422	0.0026	CcSEcCtD
Pyrazinamide—Hypersensitivity—Pilocarpine—glaucoma	0.000418	0.00258	CcSEcCtD
Pyrazinamide—Pruritus—Brinzolamide—glaucoma	0.000418	0.00258	CcSEcCtD
Pyrazinamide—Vomiting—Acetazolamide—glaucoma	0.000417	0.00257	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Clonidine—glaucoma	0.000413	0.00255	CcSEcCtD
Pyrazinamide—Myalgia—Betaxolol—glaucoma	0.000412	0.00254	CcSEcCtD
Pyrazinamide—Arthralgia—Betaxolol—glaucoma	0.000412	0.00254	CcSEcCtD
Pyrazinamide—Discomfort—Betaxolol—glaucoma	0.000407	0.00251	CcSEcCtD
Pyrazinamide—Pruritus—Pilocarpine—glaucoma	0.000402	0.00248	CcSEcCtD
Pyrazinamide—Rash—Brimonidine—glaucoma	0.000397	0.00245	CcSEcCtD
Pyrazinamide—Dermatitis—Brimonidine—glaucoma	0.000396	0.00244	CcSEcCtD
Pyrazinamide—AOX1—Effects of Nitric Oxide—NOS3—glaucoma	0.000395	0.0756	CbGpPWpGaD
Pyrazinamide—Decreased appetite—Clonidine—glaucoma	0.000394	0.00243	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Clonidine—glaucoma	0.000391	0.00241	CcSEcCtD
Pyrazinamide—Nausea—Acetazolamide—glaucoma	0.000389	0.0024	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Betaxolol—glaucoma	0.000386	0.00238	CcSEcCtD
Pyrazinamide—Vomiting—Dorzolamide—glaucoma	0.000382	0.00236	CcSEcCtD
Pyrazinamide—Rash—Dorzolamide—glaucoma	0.000379	0.00234	CcSEcCtD
Pyrazinamide—Dermatitis—Dorzolamide—glaucoma	0.000378	0.00233	CcSEcCtD
Pyrazinamide—Rash—Travoprost—glaucoma	0.000377	0.00233	CcSEcCtD
Pyrazinamide—Dermatitis—Travoprost—glaucoma	0.000377	0.00232	CcSEcCtD
Pyrazinamide—Anorexia—Betaxolol—glaucoma	0.000376	0.00232	CcSEcCtD
Pyrazinamide—Vomiting—Brinzolamide—glaucoma	0.000375	0.00232	CcSEcCtD
Pyrazinamide—Nausea—Brimonidine—glaucoma	0.000374	0.0023	CcSEcCtD
Pyrazinamide—Feeling abnormal—Clonidine—glaucoma	0.000373	0.0023	CcSEcCtD
Pyrazinamide—Rash—Brinzolamide—glaucoma	0.000372	0.0023	CcSEcCtD
Pyrazinamide—Dermatitis—Brinzolamide—glaucoma	0.000372	0.00229	CcSEcCtD
Pyrazinamide—XDH—Effects of Nitric Oxide—NOS3—glaucoma	0.000367	0.0703	CbGpPWpGaD
Pyrazinamide—Vomiting—Pilocarpine—glaucoma	0.000361	0.00223	CcSEcCtD
Pyrazinamide—Urticaria—Clonidine—glaucoma	0.00036	0.00222	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000359	0.00222	CcSEcCtD
Pyrazinamide—Body temperature increased—Clonidine—glaucoma	0.000358	0.00221	CcSEcCtD
Pyrazinamide—Rash—Pilocarpine—glaucoma	0.000358	0.00221	CcSEcCtD
Pyrazinamide—Dermatitis—Pilocarpine—glaucoma	0.000357	0.00221	CcSEcCtD
Pyrazinamide—Nausea—Dorzolamide—glaucoma	0.000357	0.0022	CcSEcCtD
Pyrazinamide—Nausea—Travoprost—glaucoma	0.000355	0.00219	CcSEcCtD
Pyrazinamide—Nausea—Brinzolamide—glaucoma	0.000351	0.00216	CcSEcCtD
Pyrazinamide—Dyspepsia—Betaxolol—glaucoma	0.000347	0.00214	CcSEcCtD
Pyrazinamide—Decreased appetite—Betaxolol—glaucoma	0.000343	0.00212	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Betaxolol—glaucoma	0.000341	0.0021	CcSEcCtD
Pyrazinamide—Nausea—Pilocarpine—glaucoma	0.000337	0.00208	CcSEcCtD
Pyrazinamide—Myalgia—Timolol—glaucoma	0.000336	0.00207	CcSEcCtD
Pyrazinamide—Arthralgia—Timolol—glaucoma	0.000336	0.00207	CcSEcCtD
Pyrazinamide—Hypersensitivity—Clonidine—glaucoma	0.000334	0.00206	CcSEcCtD
Pyrazinamide—Discomfort—Timolol—glaucoma	0.000332	0.00205	CcSEcCtD
Pyrazinamide—Feeling abnormal—Betaxolol—glaucoma	0.000325	0.00201	CcSEcCtD
Pyrazinamide—Pruritus—Clonidine—glaucoma	0.000321	0.00198	CcSEcCtD
Pyrazinamide—Urticaria—Betaxolol—glaucoma	0.000313	0.00193	CcSEcCtD
Pyrazinamide—Body temperature increased—Betaxolol—glaucoma	0.000312	0.00192	CcSEcCtD
Pyrazinamide—Anorexia—Timolol—glaucoma	0.000307	0.0019	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Timolol—glaucoma	0.000294	0.00181	CcSEcCtD
Pyrazinamide—Hypersensitivity—Betaxolol—glaucoma	0.000291	0.00179	CcSEcCtD
Pyrazinamide—Vomiting—Clonidine—glaucoma	0.000288	0.00178	CcSEcCtD
Pyrazinamide—Rash—Clonidine—glaucoma	0.000286	0.00176	CcSEcCtD
Pyrazinamide—Dermatitis—Clonidine—glaucoma	0.000285	0.00176	CcSEcCtD
Pyrazinamide—Dyspepsia—Timolol—glaucoma	0.000284	0.00175	CcSEcCtD
Pyrazinamide—Decreased appetite—Timolol—glaucoma	0.00028	0.00173	CcSEcCtD
Pyrazinamide—Pruritus—Betaxolol—glaucoma	0.000279	0.00172	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Timolol—glaucoma	0.000278	0.00172	CcSEcCtD
Pyrazinamide—Nausea—Clonidine—glaucoma	0.000269	0.00166	CcSEcCtD
Pyrazinamide—Feeling abnormal—Timolol—glaucoma	0.000266	0.00164	CcSEcCtD
Pyrazinamide—Urticaria—Timolol—glaucoma	0.000256	0.00158	CcSEcCtD
Pyrazinamide—Body temperature increased—Timolol—glaucoma	0.000255	0.00157	CcSEcCtD
Pyrazinamide—Vomiting—Betaxolol—glaucoma	0.000251	0.00155	CcSEcCtD
Pyrazinamide—Rash—Betaxolol—glaucoma	0.000249	0.00153	CcSEcCtD
Pyrazinamide—Dermatitis—Betaxolol—glaucoma	0.000249	0.00153	CcSEcCtD
Pyrazinamide—Hypersensitivity—Timolol—glaucoma	0.000237	0.00146	CcSEcCtD
Pyrazinamide—Nausea—Betaxolol—glaucoma	0.000234	0.00145	CcSEcCtD
Pyrazinamide—XDH—Oxidative Stress—SOD1—glaucoma	0.000231	0.0441	CbGpPWpGaD
Pyrazinamide—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.000228	0.0437	CbGpPWpGaD
Pyrazinamide—Pruritus—Timolol—glaucoma	0.000228	0.00141	CcSEcCtD
Pyrazinamide—Vomiting—Timolol—glaucoma	0.000205	0.00126	CcSEcCtD
Pyrazinamide—Rash—Timolol—glaucoma	0.000203	0.00125	CcSEcCtD
Pyrazinamide—Dermatitis—Timolol—glaucoma	0.000203	0.00125	CcSEcCtD
Pyrazinamide—AOX1—Tryptophan metabolism—CYP1B1—glaucoma	0.000198	0.0378	CbGpPWpGaD
Pyrazinamide—XDH—Nucleotide metabolism—TXN—glaucoma	0.000195	0.0373	CbGpPWpGaD
Pyrazinamide—Nausea—Timolol—glaucoma	0.000191	0.00118	CcSEcCtD
Pyrazinamide—XDH—Selenium Micronutrient Network—TXN—glaucoma	0.000177	0.0339	CbGpPWpGaD
Pyrazinamide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000157	0.03	CbGpPWpGaD
Pyrazinamide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000143	0.0273	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000139	0.0267	CbGpPWpGaD
Pyrazinamide—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00011	0.0211	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—ABCA1—glaucoma	0.000109	0.0209	CbGpPWpGaD
Pyrazinamide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000108	0.0206	CbGpPWpGaD
Pyrazinamide—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000106	0.0203	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—SOD1—glaucoma	9.76e-05	0.0187	CbGpPWpGaD
Pyrazinamide—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	8.4e-05	0.0161	CbGpPWpGaD
Pyrazinamide—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	8.2e-05	0.0157	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—MTHFR—glaucoma	7.74e-05	0.0148	CbGpPWpGaD
Pyrazinamide—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	7.25e-05	0.0139	CbGpPWpGaD
Pyrazinamide—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	6.55e-05	0.0125	CbGpPWpGaD
Pyrazinamide—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	6.33e-05	0.0121	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NARFL—glaucoma	6.06e-05	0.0116	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CA5A—glaucoma	6.06e-05	0.0116	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CA5A—glaucoma	5.63e-05	0.0108	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NARFL—glaucoma	5.63e-05	0.0108	CbGpPWpGaD
Pyrazinamide—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	5.6e-05	0.0107	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	5.59e-05	0.0107	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—LRP12—glaucoma	5.48e-05	0.0105	CbGpPWpGaD
Pyrazinamide—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	5.36e-05	0.0102	CbGpPWpGaD
Pyrazinamide—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	5.06e-05	0.00967	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—PTGS2—glaucoma	4.93e-05	0.00944	CbGpPWpGaD
Pyrazinamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	4.93e-05	0.00942	CbGpPWpGaD
Pyrazinamide—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	4.53e-05	0.00866	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	3.87e-05	0.0074	CbGpPWpGaD
Pyrazinamide—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	3.87e-05	0.0074	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	3.87e-05	0.0074	CbGpPWpGaD
Pyrazinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	3.8e-05	0.00727	CbGpPWpGaD
Pyrazinamide—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	3.68e-05	0.00704	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	3.62e-05	0.00692	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FGFR1OP—glaucoma	3.53e-05	0.00676	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HEYL—glaucoma	3.53e-05	0.00676	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—TNF—glaucoma	3.33e-05	0.00637	CbGpPWpGaD
Pyrazinamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	3.13e-05	0.00598	CbGpPWpGaD
Pyrazinamide—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	3.09e-05	0.0059	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	2.99e-05	0.00571	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CA1—glaucoma	2.96e-05	0.00566	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—GSTT1—glaucoma	2.89e-05	0.00553	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CTSA—glaucoma	2.87e-05	0.00548	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CA1—glaucoma	2.75e-05	0.00526	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CA2—glaucoma	2.71e-05	0.00518	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CTSA—glaucoma	2.66e-05	0.0051	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.54e-05	0.00485	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CA2—glaucoma	2.52e-05	0.00481	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	2.41e-05	0.00462	CbGpPWpGaD
Pyrazinamide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.38e-05	0.00456	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HDAC9—glaucoma	2.21e-05	0.00422	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.96e-05	0.00374	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—TXN—glaucoma	1.91e-05	0.00365	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—GSTM1—glaucoma	1.84e-05	0.00352	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—TXN—glaucoma	1.77e-05	0.00339	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	1.74e-05	0.00334	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTT1—glaucoma	1.69e-05	0.00323	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	1.65e-05	0.00316	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	1.65e-05	0.00316	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	1.63e-05	0.00312	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTT1—glaucoma	1.48e-05	0.00283	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTT1—glaucoma	1.37e-05	0.00263	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	1.37e-05	0.00263	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP1B1—glaucoma	1.35e-05	0.00258	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	1.33e-05	0.00254	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTT1—glaucoma	1.3e-05	0.0025	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.26e-05	0.00241	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN2B—glaucoma	1.19e-05	0.00227	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NARFL—glaucoma	1.19e-05	0.00227	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CA5A—glaucoma	1.19e-05	0.00227	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ABCA1—glaucoma	1.18e-05	0.00225	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP1B1—glaucoma	1.18e-05	0.00225	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	1.18e-05	0.00225	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	1.18e-05	0.00225	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ABCA1—glaucoma	1.1e-05	0.00209	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP1B1—glaucoma	1.1e-05	0.00209	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTM1—glaucoma	1.08e-05	0.00206	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	1.06e-05	0.00203	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.04e-05	0.00199	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.03e-05	0.00196	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MTHFR—glaucoma	9.94e-06	0.0019	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTM1—glaucoma	9.42e-06	0.0018	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APOE—glaucoma	9.25e-06	0.00177	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CAV1—glaucoma	9.17e-06	0.00175	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CA5A—glaucoma	9.15e-06	0.00175	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NARFL—glaucoma	9.15e-06	0.00175	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTM1—glaucoma	8.76e-06	0.00167	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—BAD—glaucoma	8.62e-06	0.00165	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—MTHFR—glaucoma	8.32e-06	0.00159	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTM1—glaucoma	8.31e-06	0.00159	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	8.2e-06	0.00157	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOE—glaucoma	7.75e-06	0.00148	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—MTHFR—glaucoma	7.74e-06	0.00148	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CAV1—glaucoma	7.68e-06	0.00147	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOE—glaucoma	7.2e-06	0.00138	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CAV1—glaucoma	7.14e-06	0.00137	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS3—glaucoma	6.93e-06	0.00133	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTGS2—glaucoma	6.34e-06	0.00121	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN1B—glaucoma	6.01e-06	0.00115	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NOS3—glaucoma	5.81e-06	0.00111	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CA1—glaucoma	5.79e-06	0.00111	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CTSA—glaucoma	5.6e-06	0.00107	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NOS3—glaucoma	5.4e-06	0.00103	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTGS2—glaucoma	5.31e-06	0.00102	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CA2—glaucoma	5.29e-06	0.00101	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.17e-06	0.000989	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.17e-06	0.000989	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTGS2—glaucoma	4.94e-06	0.000944	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CA1—glaucoma	4.47e-06	0.000854	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CTSA—glaucoma	4.33e-06	0.000827	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CA2—glaucoma	4.08e-06	0.000781	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TXN—glaucoma	3.73e-06	0.000713	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.4e-06	0.000651	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.37e-06	0.000645	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTT1—glaucoma	2.89e-06	0.000553	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TXN—glaucoma	2.88e-06	0.00055	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.33e-06	0.000446	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCA1—glaucoma	2.3e-06	0.000441	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP1B1—glaucoma	2.3e-06	0.000441	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTT1—glaucoma	2.23e-06	0.000427	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM1—glaucoma	1.84e-06	0.000352	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCA1—glaucoma	1.78e-06	0.00034	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP1B1—glaucoma	1.78e-06	0.00034	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTHFR—glaucoma	1.63e-06	0.000311	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOE—glaucoma	1.52e-06	0.00029	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CAV1—glaucoma	1.5e-06	0.000287	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM1—glaucoma	1.42e-06	0.000272	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTHFR—glaucoma	1.26e-06	0.00024	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOE—glaucoma	1.17e-06	0.000224	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CAV1—glaucoma	1.16e-06	0.000222	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NOS3—glaucoma	1.14e-06	0.000217	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTGS2—glaucoma	1.04e-06	0.000199	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NOS3—glaucoma	8.76e-07	0.000168	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTGS2—glaucoma	8.01e-07	0.000153	CbGpPWpGaD
